Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate vs Lidocaine for Laryngospasm in Tonsillectomy
NCT06761547Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in laryngospasm and postoperative pain comparing Magnesium Sulfate, Lidocaine and Placebo (3 arms). Primary endpoint: The incidence of laryngospasm in three groups at 24 hours. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
magnesium sulfateLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
laryngospasmpostoperative pain
Beyond the preview
Go deeper on NCT06761547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06761547.